Vijay Raturi

Dr. Vijay Raturi

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2020 in Head & Neck
Verified
Journal Article
Closed access
PDF file
VRVijay Raturi
Vijay Raturi
HHHidehiro Hojo
Hidehiro Hojo
MBM. L. B. Bhatt
M. L. B. Bhatt
MSMohammad Suhel
Mohammad Suhel
CWChen‐Ta Wu
Chen‐Ta Wu
JGJalaj Gaur
Jalaj Gaur

23 October 2020 in Frontiers in Oncology
Verified
Journal Article
Open access
PDF file
VRVijay Raturi
Vijay Raturi
TTTaku Tochinai
Taku Tochinai
HHHidehiro Hojo
Hidehiro Hojo
TRToshiya Rachi
Toshiya Rachi
KHKenji Hotta
Kenji Hotta
TATetsuo Akimoto
Tetsuo Akimoto
Background: Radiobiological model-based studies of photon-modulated radiotherapy for pancreatic cancer have reported reduced gastrointestinal (GI) toxicity, although the risk is still high. The purpose of this study was to investigate the potential of 3D-passive scattering proton beam therapy (3D-PSPBT) in limiting GI organ at risk (OAR) toxicity in localized pancreatic cancer based on dosimetric data and the normal tissue complication probability (NTCP) model. Methods: The data of 24 pancreatic cancer patients were retrospectively analyzed, and these patients were planned with intensity-modulated radiotherapy (IMRT), volume-modulated arc therapy (VMAT), and 3D-PSPBT. The tumor was targeted without elective nodal coverage. All generated plans consisted of a 50.4-GyE (Gray equivalent) dose in 28 fractions with equivalent OAR constraints, and they were normalized to cover 50% of the planning treatment volume (PTV) with 100% of the prescription dose. Physical dose distributions were evaluated. GI-OAR toxicity risk for different endpoints was estimated by using published NTCP Lyman–Kutcher–Burman (LKB) models. Analysis of variance (ANOVA) was performed to compare the dosimetric data, and ΔNTCPIMRT−PSPBT and ΔNTCPVMAT−PSPBT were also computed. Results: Similar homogeneity and conformity for the clinical target volume (CTV) and PTV were exhibited by all three planning techniques (P > 0.05). 3D-PSPBT resulted in a significant dose reduction for GI-OARs in both the low-intermediate dose range (below 30 GyE) and the highest dose region (Dmax and V50 GyE) in comparison with IMRT and VMAT (P < 0.05). Based on the NTCP evaluation, the NTCP reduction for GI-OARs by 3D-PSPBT was minimal in comparison with IMRT and VMAT. Conclusion: 3D-PSPBT results in minimal NTCP reduction and has less potential to substantially reduce the toxicity risk of upper GI bleeding, ulceration, obstruction, and perforation endpoints compared to IMRT and VMAT. 3D-PSPBT may have the potential to reduce acute dose-limiting toxicity in the form of nausea, vomiting, and diarrhea by reducing the GI-OAR treated volume in the low-to-intermediate dose range. However, this result needs to be further evaluated in future clinical studies.

1 July 2021 in Cancer/Radiothérapie
Verified
Journal Article
Closed access
TBTANJU BERBER
TANJU BERBER
VRVijay Raturi
Vijay Raturi
FAF. Aksaray
F. Aksaray
HHH. Hojo
H. Hojo
TFT. Fujisawa
T. Fujisawa
HOH. Ohyoshi
H. Ohyoshi

15 October 2019 in Asia-Pacific Journal of Clinical Oncology
Verified
Journal Article
Closed access
PDF file
VRVijay Raturi
Vijay Raturi
CWChen‐Ta Wu
Chen‐Ta Wu
SMSuhel Mohammad
Suhel Mohammad
HHHidehiro Hojo
Hidehiro Hojo
YBYanping Bei
Yanping Bei
NSNaoyuki Shigematsu
Naoyuki Shigematsu

1 January 2019 in Journal of Oral Biology and Craniofacial Research
Verified
Journal Article
Open access
VRVijay Raturi
Vijay Raturi
RKRajendra Kumar
Rajendra Kumar
MBMadan Lal Brahma Bhatt
Madan Lal Brahma Bhatt
RSRahul Kunwar Singh
Rahul Kunwar Singh
DPDevendra Parmar
Devendra Parmar
TKTridiv Katiyar
Tridiv Katiyar
The correlation of XRCC-1 Gene Arg194Trp polymorphism with alcohol and tobacco substance user and with loco-regionally progressed squamous cell cancer of the larynx (LSCC) was assessed in this research study. The result of this research study is described herein. A tertiary hospital-based observational case-control research was carried out. DNA segregation and Genotype examination were done from the blood sample of the control group and cases to know the correlation between XRCC-1 gene polymorphism with loco-regionally progressed LSCC and with hazard factors tobacco and alcohol. In the cases, the existence of DNA repair XRCC-1 gene polymorphic variants (Hetero CT and Mutant TT) was recognizable in contrary to the control group arm. The XRCC-1 gene polymorphic hetero (CT) genotype (O.R-1.96; 95% C.I: 1.23-3.13; P < 0.004) and mutant (TT) genotype variants (O.R-1.95; 95% C.I: 0.59-6.44; P = 0.27) was correlated with access hazard of loco-regionally progressed LSCC, and its statistically convincing for polymorphic hetero (CT) variant. The data were adapted for the age of the patients and control group, circadian alcohol intake, tobacco chewing habits, and the tobacco smoking habits during application of multivariate logistic regression. Its apparent that the hazard is amalgamated with hetero (CT) genotype variant (O.R- 1.67; 95% C.I: 0.98-2.82; P = 0.05) and mutant (TT) genotype variant (O.R- 1.62; 95% C.I: 0.88-2.78; P = 0.11) and its statistically convincing for polymorphic hetero (CT) genotype variant. Cases with the record of substance use (alcohol and tobacco) have an abundance of XRCC-1 hetero (CT) and mutant (TT) genotype variants in allegory to control group. Increased hazard is related with XRCC-1 hetero (CT) variant in smokers (O.R 3.28; 95% C.I: 1.45-7.41; P = 0.004), in tobacco chewers (O.R-3.79; 95% C.I: 1.87-7.71; P = 0.0002), and in alcohol consumers (O.R- 4.24; 95% C.I: 2.21-8.15; P= <0.0001) which is statistically significant. This research investigation demonstrates the correlation of XRCC-1 polymorphic hetero genotype (CT) & mutant genotype (TT) variants as hazard factor in loco-regionally progressed LSCC. Cases with the record of alcohol intake habits, tobacco smoking and chewing habits and XRCC-1 hetero genotype (CT) variant have statistically increased the hazard of loco-regionally progressed LSCC, which demonstrate the role of gene-ecological interconnection in modifying the vulnerability of loco-regionally progressed LSCC.

7 February 2020 in Head & Neck
Verified
Journal Article
Closed access
PDF file
MOMasayuki Okumura
Masayuki Okumura
AMAtsushi Motegi
Atsushi Motegi
SZSadamoto Zenda
Sadamoto Zenda
NNNaoki Nakamura
Naoki Nakamura
HHHidehiro Hojo
Hidehiro Hojo
TATetsuo Akimoto
Tetsuo Akimoto